International Graphite Limited (IG6.AX)
AUD 0.04
(-11.11%)
AUD 0.04
(-11.11%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.57 Million | -1.84 Million | -1.83 Million | -738.95 Thousand | -605.28 Thousand | -714.36 Thousand |
| Net Income | -4.01 Million | -2.53 Million | -2.05 Million | -2.09 Million | -1.44 Million | -975.7 Thousand |
| Depreciation & Amortization | 194.45 Thousand | 73.37 Thousand | 34.54 Thousand | 5756.00 | - | - |
| Deferred income taxes | - | -122.59 Thousand | -425.87 Thousand | 187.23 Thousand | - | - |
| Stock-based compensation | 895.82 Thousand | 456.28 | 556.66 | 1167.80 | 946.26 | 324.91 |
| Change in working capital | 134.24 Thousand | 157.07 Thousand | -371.56 Thousand | 185.06 Thousand | -111.06 Thousand | -63.57 Thousand |
| Other non-cash items | 213.39 Thousand | 578.41 Thousand | 981.97 Thousand | 974.54 Thousand | 1.05 Million | 388.48 Thousand |
| Investing Cash Flow | 510.46 Thousand | -4.31 Million | -471.83 Thousand | -234.9 Thousand | - | - |
| Investments in PPE | -2.56 Million | -5.98 Million | -470.5 Thousand | -234.9 Thousand | - | - |
| Acquisitions | - | -0.64 | -1.33 | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 3.07 Million | 1.66 Million | -1328.67 | - | - | - |
| Financing Cash Flow | 2.68 Million | 21.19 Thousand | 10.5 Million | 1.58 Million | 540 Thousand | 828 Thousand |
| Debt repayment | -433.85 Thousand | -30.20 | -33.48 | -5.55 | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -712.12 Thousand | - | - | - |
| Common Stock Issuance | 3.24 Million | - | 11.25 Million | 1.58 Million | 540 Thousand | 828 Thousand |
| Other Financing Activities | 2.24 Million | 21.19 Thousand | -33.41 Thousand | 1586.00 | 540.00 | 828.00 |
| Accounts receivables | 115.32 Thousand | 14.97 Thousand | -460.67 Thousand | 154.48 Thousand | -3299.00 | -183.11 Thousand |
| Accounts payables | 213.39 Thousand | 9635.00 | 104.44 Thousand | 45.42 Thousand | -107.77 Thousand | 119.54 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 134.24 Thousand | 132.46 Thousand | -15.32 Thousand | -14.84 Thousand | - | - |
| Cash at beginning of period | 2.71 Million | 8.85 Million | 661.14 Thousand | 49.7 Thousand | 114.98 Thousand | 1351.00 |
| Cash at end of period | 3.32 Million | 2.71 Million | 8.85 Million | 661.14 Thousand | 49.7 Thousand | 114.98 Thousand |
| Capital Expenditure | -2.56 Million | -5.98 Million | -470.5 Thousand | -234.9 Thousand | - | - |
| Effect of forex changes on cash | - | 6.13 Million | - | 4.85 | - | - |
| Net cash flow / Change in cash | 613.62 Thousand | -6.14 Million | 8.19 Million | 611.43 Thousand | -65.28 Thousand | 113.63 Thousand |
| Free Cash Flow | -5.14 Million | -7.82 Million | -2.3 Million | -973.86 Thousand | -605.28 Thousand | -714.36 Thousand |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1027.24 | -1027.24 | -981.50 | -981.50 | -1.58 Million | -2.53 Million |
| Depreciation & Amortization | 97.23 | 97.23 | 41.85 Thousand | - | 22.6 Thousand | 73.37 Thousand |
| Deferred income taxes | - | - | - | - | -45.49 Thousand | -122.59 Thousand |
| Stock-based compensation | 134.22 | 134.22 | 313.69 | 313.69 | 214.75 | 456.28 |
| Change in working capital | 67.12 | 67.12 | - | - | 73.72 | 157.07 Thousand |
| Other non-cash items | 403.57 | 403.57 | -296.87 | -296.87 | 718.73 Thousand | 578.41 Thousand |
| Investing Cash Flow | 206.79 | 206.79 | 48.45 | 48.45 | -1.35 Million | -4.31 Million |
| Investments in PPE | -481.25 | -481.25 | -803.36 | -803.36 | -2.9 Million | -5.98 Million |
| Acquisitions | - | - | - | - | -0.32 | -0.64 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 688.03 | 688.03 | 851.81 | 851.81 | 1.54 Million | 1.66 Million |
| Financing Cash Flow | 1017.86 | 1017.86 | 323.50 | 323.50 | 40.88 Thousand | 21.19 Thousand |
| Debt repayment | -1.39 Million | - | -897 Thousand | - | - | -30.20 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 3.24 Million | - | - | - | - | - |
| Other Financing Activities | 1017.86 | 1017.86 | 323.50 | 323.50 | -9000.00 | 21.19 Thousand |
| Accounts receivables | - | - | - | - | - | 14.97 Thousand |
| Accounts payables | - | - | - | - | - | 9635.00 |
| Inventory | - | - | - | - | - | - |
| Other working capital | 67.12 | 67.12 | - | - | 73.72 | 132.46 Thousand |
| Cash at beginning of period | 1.52 Million | - | 2.71 Million | - | 4.91 Million | 8.85 Million |
| Cash at end of period | 3.26 Million | 899.54 | 1.52 Million | -592.73 | 2.71 Million | 2.71 Million |
| Capital Expenditure | -481.25 | -481.25 | -803.36 | -803.36 | -2.9 Million | -5.98 Million |
| Effect of forex changes on cash | - | - | - | - | - | 6.13 Million |
| Net cash flow / Change in cash | 1.73 Million | 899.54 | -1.18 Million | -592.73 | -2.2 Million | -6.14 Million |
| Free Cash Flow | -806.35 | -806.35 | -1768.04 | -1768.04 | -3.79 Million | -7.82 Million |
ALGWF
EXMT
J
JAGSNPHARM
6262
WEWIN